Stock HBIO HARVARD BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Harvard Bioscience, Inc.

Equities

HBIO

US4169061052

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
3.17 USD +1.60% Intraday chart for Harvard Bioscience, Inc. +0.32% -40.75%
May. 07 Transcript : Harvard Bioscience, Inc., Q1 2024 Earnings Call, May 07, 2024
May. 07 Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 Revenue $24.5M MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 Revenue $24.5M
MT
Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 EPS $0.02
MT
Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Harvard Bioscience, Inc. Provides Earnings Guidance for the Full Year 2024
CI
Harvard Bioscience Reducing Headcount
MT
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q4 Revenue $28.2M
MT
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q4 EPS $0.04
MT
Harvard Bioscience, Inc. Provides Revenue Guidance for the Full Year 2024
CI
Harvard Bioscience, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications At Society of Toxicology Meeting
CI
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q3 Revenue $25.4M
MT
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q3 EPS $0.01
MT
HARVARD BIOSCIENCE INC - REMAIN ON PATH TO REDUCING NET LEVERAGE…
RE
Harvard Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Harvard Bioscience, Inc. Provides Revenue Guidance for the Year 2023
CI
Harvard Bioscience, Inc. to Showcase Latest Innovations in Preclinical and Organoid Research At Society for Neuroscience Conference
CI
Harvard Bioscience Unit Named as Exclusive Distributor of Etisense's Cardiorespiratory Monitoring Product
MT
Harvard Bioscience Seeks Acquisitions
CI
Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q2 EPS $0.04, vs. Street Est of $0.06
MT
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q2 Revenue $28.8M, vs. Street Est of $29.5M
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HBIO Stock
  4. News Harvard Bioscience, Inc.
  5. Highlights